Regional citrate anticoagulation for hemodialysis: A safe and efficient method

Regional citrate anticoagulation for hemodialysis: A safe and efficient method

Bibliographic Details
Main Authors:	Jarraya Faical, Mkawar Khaled, Kammoun Khawla, Hdiji Abdelhamid, Yaich Somaya, Kharrat Mahmoud, Charfeddine Khaled, Hmida Mohamed, Mahfoudh Hichem, Ayedi Fatma, Hachicha Jamil
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2010-01-01
Series:	Saudi Journal of Kidney Diseases and Transplantation
Online Access:	http://www.sjkdt.org/article.asp?issn=1319-2442;year=2010;volume=21;issue=3;spage=533;epage=534;aulast=Jarraya

Similar Items

Living and cadaver donor transplant programs in the maghreb
by: Jamil Hachicha, et al.
Published: (2013-01-01)

Tumoral calcinosis, calciphylaxis, hyperparathyroidism and tuberculosis in a dialysis patient
by: Khawla Kammoun, et al.
Published: (2011-01-01)

Identification of compound heterozygous patients with primary hyperoxaluria type 1: clinical evaluations and in silico investigations
by: Houda Kanoun, et al.
Published: (2017-10-01)

Fatal outcome due to sirolimus-induced acute hepatitis, myelosuppression and fever in a kidney allograft recipient
by: Soumaya Yaich, et al.
Published: (2013-01-01)

Secondary oxalosis due to excess vitamin C intake: A cause of graft loss in a renal transplant recipient
by: S Yaich, et al.
Published: (2014-01-01)

Acute hemodialysis effects on doppler echocardiographic indices
by: Leila Abid, et al.
Published: (2014-01-01)

Crystalline nephropathy in renal transplant: A series of 4 cases
by: K Mnif, et al.
Published: (2018-01-01)

Autosomal Dominant <i>Alport′s syndrome</i>: Study of a Large Tunisian Family
by: Kharrat M, et al.
Published: (2006-01-01)

Poor prognostic factors of lupus nephritis
by: Khawla Kammoun, et al.
Published: (2011-01-01)

Angiogenic activity in the sera of patients with post-kidney transplant erythrocytosis
by: Chokri Maktouf, et al.
Published: (2014-01-01)

Atypical presentation of cutaneous leishmaniasis in a renal transplant recipient successfully treated with allopurinol and fluconazole
by: Soumaya Yaich, et al.
Published: (2013-03-01)

Hemodiafiltration using pre-dilutional on-line citrate dialysate: A new technique for regional citrate anticoagulation: A feasibility study
by: Radhouane Bousselmi, et al.
Published: (2015-01-01)

Use of a pelvic kidney for living transplantation
by: Soumaya Yaich, et al.
Published: (2014-01-01)

BK virus-associated hemophagocytic syndrome in a renal transplant recipient
by: S Yaich, et al.
Published: (2014-01-01)

Cystatin C: A prognostic marker after myocardial infarction in patients without chronic kidney disease
by: Leila Abid, et al.
Published: (2016-07-01)

Citrate Anticoagulation for CRRT in Children: Comparison with Heparin
by: Sara Nicole Fernández, et al.
Published: (2014-01-01)

Complications of regional citrate anticoagulation: accumulation or overload?
by: Antoine G. Schneider, et al.
Published: (2017-11-01)

Factors Predisposing to Post-Renal Transplant Erythrocytosis: A Retrospective Study
by: Charfeddine K, et al.
Published: (2008-01-01)

Simultaneous <i>Hodgkin′s disease</i> and kaposi sarcoma in a renal transplant recipient
by: Yaich S, et al.
Published: (2010-01-01)

Simple citrate anticoagulation protocol for low flux haemodialysis
by: Eng Kuang Lim, et al.
Published: (2018-01-01)

Evaluating the efficacy of citrate anticoagulation during CRRT in cardiac patients
by: А. М. Караськов, et al.
Published: (2015-10-01)

Is Anticoagulation Discontinuation Achievable with Citrate Dialysate during HDF Sessions?
by: Thibault Dolley-Hitze, et al.
Published: (2016-01-01)

Regional citrate anticoagulation for intermittent hemodialysis in the intensive care: what is the optimal setup?
by: Jakob Gubensek, et al.
Published: (2021-05-01)

Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis
by: Ilan Lenga, et al.
Published: (2019-12-01)

Effect of regional citrate anticoagulation on critical patients with continuous renal replacement therapy
by: Li-Li You
Published: (2016-12-01)

Factors affecting the safe use of oral anticoagulants
by: Abohelaika, Salah Ahmed O.
Published: (2017)

Comparative evaluation of the methods of continuous hemodiafiltration and hemofiltration with citrate anticoagulation in cardiac surgery patients
by: А. С. Борисов, et al.
Published: (2015-10-01)

Citrate Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients: Success and Limits
by: Filippo Mariano, et al.
Published: (2011-01-01)

Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.
by: Keila Rodriguez, et al.
Published: (2017-01-01)

Regional citrate anticoagulation “non-shock” protocol with pre-calculated flow settings for patients with at least 6 L/hour liver citrate clearance
by: Lenar Yessayan, et al.
Published: (2021-07-01)

Anticoagulation in COVID-19: why, what, and when
by: Khaled M Taema
Published: (2021-01-01)

Modified regional citrate anticoagulation is optimal for hemodialysis in patients at high risk of bleeding: a prospective randomized study of three anticoagulation strategies
by: Ting Lin, et al.
Published: (2019-12-01)

Chylous peritonitis in peritoneal dialysis
by: Hanen Abid, et al.
Published: (2021-09-01)

Clinical efficacy and individualized scheme of segmented citrate anticoagulation in dialysis of patients with high risk of bleeding
by: PAN Xin, et al.
Published: (2021-07-01)

Thrombin Generation and Platelet Function in ICU Patients Undergoing CVVHD Using Regional Citrate Anticoagulation
by: Marion Wiegele, et al.
Published: (2021-06-01)

Abscisic Acid, Stress, and Ripening (TtASR1) Gene as a Functional Marker for Salt Tolerance in Durum Wheat
by: Karama Hamdi, et al.
Published: (2020-01-01)

Golden hour for fibrinogen concentrate infusion to improve post partum hemorrhage
by: Anouar Jarraya, et al.
Published: (2018-04-01)

Sildenafil citrate therapy for secondary pulmonary arterial hypertension due to chronic obstructive lung disease
by: Khaled Alkhayat, et al.
Published: (2016-10-01)

Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study.
by: Yan Yu, et al.
Published: (2020-01-01)

Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study
by: Yan Yu, et al.
Published: (2020-01-01)